Intensity Total Assets from 2010 to 2026

INTS Stock

0.41 0.01 2.38%

Intensity Therapeutics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2026. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

4.3 M

Current Value

6.4 M

Quarterly Volatility

3.3 M

Credit Downgrade

Yuan Drop

Covid

Check Intensity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intensity Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 379.2 K, Interest Income of 379.2 K or Depreciation And Amortization of 21.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.93. Intensity financial statements analysis is a perfect complement when working with Intensity Therapeutics Valuation or Volatility modules.

Build AI portfolio with Intensity Stock

Check out the analysis of Intensity Therapeutics Correlation against competitors.

Latest Intensity Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Intensity Therapeutics Common over the last few years. Total assets refers to the total amount of Intensity Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Intensity Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Intensity Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intensity Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 4.78 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Intensity Total Assets Regression Statistics

	Arithmetic Mean	8,235,098
	Geometric Mean	7,497,595
	Coefficient Of Variation	39.98
	Mean Deviation	2,198,479
	Median	9,006,334
	Standard Deviation	3,292,116
	Sample Variance	10.8T
	Range	15.5M
	R-Value	(0.28)
	Mean Square Error	10.6T
	R-Squared	0.08
	Significance	0.27
	Slope	(185,095)
	Total Sum of Squares	173.4T

Intensity Total Assets History

	2026	6.4 M
	2025	4.3 M
	2024	4.8 M
	2023	17.3 M
	2022	1.8 M
	2021	5.2 M
	2020	10.1 M

Other Fundumenentals of Intensity Therapeutics

Intangibles To Total Assets

Intensity Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Short Long Term Debt
Total Assets		0.74	0.36	-0.83	0.3	0.41	-0.33	0.74	-0.36	0.6	0.99	-0.34	0.9	-0.57	-0.23	-0.14	-0.28
Total Stockholder Equity	0.74		0.49	-0.59	0.24	0.26	-0.47	0.78	-0.9	0.59	0.73	0.0	0.84	-0.88	0.12	-0.44	-0.27
Net Tangible Assets	0.36	0.49		-0.32	0.86	-0.61	-0.89	0.6	-0.44	-0.29	0.46	-0.49	0.67	-0.47	-0.48	-0.38	-0.83
Net Debt	-0.83	-0.59	-0.32		-0.11	-0.32	0.12	-0.33	0.26	-0.64	-0.8	-0.01	-0.81	0.7	-0.03	-0.3	0.22
Retained Earnings	0.3	0.24	0.86	-0.11		-0.67	-0.9	0.63	-0.13	-0.54	0.42	-0.74	0.53	-0.09	-0.83	-0.55	-0.9
Accounts Payable	0.41	0.26	-0.61	-0.32	-0.67		0.65	0.05	-0.09	0.86	0.29	0.39	0.08	-0.14	0.48	0.23	0.74
Net Receivables	-0.33	-0.47	-0.89	0.12	-0.9	0.65		-0.7	0.45	0.38	-0.44	0.66	-0.6	0.35	0.59	0.65	0.92
Short Term Investments	0.74	0.78	0.6	-0.33	0.63	0.05	-0.7		-0.59	0.18	0.79	-0.52	0.8	-0.45	-0.46	-0.74	-0.49
Total Liab	-0.36	-0.9	-0.44	0.26	-0.13	-0.09	0.45	-0.59		-0.44	-0.37	-0.2	-0.56	0.85	-0.34	0.5	0.19
Net Invested Capital	0.6	0.59	-0.29	-0.64	-0.54	0.86	0.38	0.18	-0.44		0.5	0.45	0.41	-0.61	0.59	0.24	0.46
Total Current Assets	0.99	0.73	0.46	-0.8	0.42	0.29	-0.44	0.79	-0.37	0.5		-0.44	0.93	-0.55	-0.33	-0.2	-0.4
Capital Stock	-0.34	0.0	-0.49	-0.01	-0.74	0.39	0.66	-0.52	-0.2	0.45	-0.44		-0.31	-0.27	0.83	0.37	0.66
Net Working Capital	0.9	0.84	0.67	-0.81	0.53	0.08	-0.6	0.8	-0.56	0.41	0.93	-0.31		-0.75	-0.29	-0.29	-0.54
Short Term Debt	-0.57	-0.88	-0.47	0.7	-0.09	-0.14	0.35	-0.45	0.85	-0.61	-0.55	-0.27	-0.75		-0.35	0.11	0.26
Common Stock	-0.23	0.12	-0.48	-0.03	-0.83	0.48	0.59	-0.46	-0.34	0.59	-0.33	0.83	-0.29	-0.35		0.42	0.66
Property Plant Equipment	-0.14	-0.44	-0.38	-0.3	-0.55	0.23	0.65	-0.74	0.5	0.24	-0.2	0.37	-0.29	0.11	0.42		0.41
Short Long Term Debt	-0.28	-0.27	-0.83	0.22	-0.9	0.74	0.92	-0.49	0.19	0.46	-0.4	0.66	-0.54	0.26	0.66	0.41

Click cells to compare fundamentals

About Intensity Therapeutics Financial Statements

Intensity Therapeutics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Intensity Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Intensity Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Intensity Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	4.3 M	6.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intensity Stock Analysis

When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC